Losartan Potassium recalls

Losartan Potassium products have been recalled 20 times, most recently on 12 Jul 2023. The recalling company is usually Macleods Pharma Usa. The most common reason is potency & assay.

Total recalls20since 2019

Last 12 months0reported

Class I00% of total

Ongoing3latest 12 Jul 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 20 100%Class III 0 0%

Why losartan potassium is recalled

Companies

Product types

Blood Pressure Medication20100%

By year

202315%
20221365%
202115%
2019525%

Ongoing losartan potassium recalls

3 active

Reported	Class	Recall	Company	Reason	Where
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 25 mg recalled by Camber PharmaceuticalsLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 100 mg recalledLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 50 mg recalled by Camber PharmaceuticalsLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide

All losartan potassium recalls, newest first

20 total

Reported	Class	Recall	Company	Reason	Where
12 Jul 2023Drug	CLASS II	Losartan Potassium Tablets, USP, 25 mg recalled by Strides PharmaLosartan Potassium	Strides Pharma	Foreign Material	Nationwide
6 Jul 2022Drug	CLASS II	Losartan Potassium Tablets, USP 25 mg recalled by PD-Rx PharmaceuticalsLosartan Potassium	PD-Rx Pharmaceuticals	Potency & Assay	Nationwide
6 Jul 2022Drug	CLASS II	Losartan Potassium Tablets, USP 100 mg recalled by PD-Rx PharmaceuticalsLosartan Potassium	PD-Rx Pharmaceuticals	Potency & Assay	Nationwide
6 Jul 2022Drug	CLASS II	Losartan Potassium Tablets, USP 50 mg recalled by PD-Rx PharmaceuticalsLosartan Potassium	PD-Rx Pharmaceuticals	Potency & Assay	Nationwide
8 Jun 2022Drug	CLASS II	Losartan Potassium Tablets, USP 25 mg recalled by Strides PharmaLosartan Potassium	Strides Pharma	Potency & Assay	Nationwide
8 Jun 2022Drug	CLASS II	Losartan Potassium Tablets, USP, 100 mg recalled by Strides PharmaLosartan Potassium	Strides Pharma	Potency & Assay	Nationwide
8 Jun 2022Drug	CLASS II	Losartan Potassium Tablets, USP, 50 mg recalled by Strides PharmaLosartan Potassium	Strides Pharma	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Losartan Potassium Tablets USP, 25 mg, a) bottles recalledLosartan Potassium	Lupin Pharmaceuticals	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Losartan Potassium Tablets USP, 50 mg, a) bottles recalledLosartan Potassium	Lupin Pharmaceuticals	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Losartan Potassium Tablets, USP, 100 mg, a) bottles recalledLosartan Potassium	Macleods Pharma Usa	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.